WESTBROOK, ME - JANUARY 4: IDEXX Laboratories has been added to the Standard & Poor's 500 Index. (Photo by Ben McCanna/Portland Portland Press Herald via Getty Images) IDEXX Laboratories’ (IDXX) ...
(MENAFN- GetNews) Air Voel, a trusted name in sleep and respiratory wellness across Canada, proudly announces the expansion of its product lineup with the latest ResMed BiPAP and CPAP machines, ...
Washington | Hearing implant pioneer Cochlear and sleep therapeutics giant ResMed have urged the Trump administration to spare their devices from tariffs, arguing vulnerable patients would be harmed, ...
ResMed Inc. (NYSE:RMD) reported better-than-expected earnings for the first quarter on Thursday. The company posted quarterly earnings of $2.55 per share which beat the analyst consensus estimate of ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Study Overview: ResMed Inc. has initiated ...
Air Voel, one of Canada’s trusted providers of sleep therapy solutions, is proud to announce a major expansion of its offerings across the country, making advanced ResMed CPAP machines more accessible ...
Fractus, a company specializing in geometry-based antenna technology and IP licensing, has filed a patent infringement suit against respiratory leader ResMed. The complaint was filed in the United ...
ResMed, an ASX healthcare leader, is well-positioned to capitalise on the growing demand for sleep apnoea treatment and digital health solutions, offering potential long-term rewards. The company's ...
ResMed plans to sign a lease for an about 446,500-square-foot building on Collins Road in Greenwood. The company is seeking a nearly $500,000 three-year tax break from the Greenwood City Council.
When Mick Farrell’s dad, Peter, first invited him to come and work at ResMed, which makes breathing devices for sleep apnoea, he scoffed at the idea. Farrell, an ambitious 26-year-old consultant, was ...
The Resmed Inc (ASX: RMD) share price is charging higher again this morning after its strong financial results late last week boosted investor confidence. At the time of writing, the Resmed share ...
Resmed Inc.’s RMD adjusted earnings per share (EPS) in the fourth quarter of fiscal 2025 were $2.55, up 22.6% year over year. The metric beat the Zacks Consensus Estimate by 3.66%. The adjustments ...